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Summary The cell kinetics of 54 colorectal tumours were examined by immunohistochemical methods, using
the monoclonal antibody DNA polymerase a which reacts with an antigen found only in proliferating cells.
The rate of DNA polymerase a positive cells in colorectal cancer was 44.8%, a figure that was significantly
higher than the 21.9% found in colorectal adenomas. The rate of DNA polymerase a positive cells tended to
rise as the degree of differentiation decreased according to the standard histological grading criteria for
colorectal cancer. Positive cells were detected in much greater numbers in tumours with liver metastasis
(55.4%) than in those without metastasis (41.7%). The rate of DNA polymerase a positive cells for aneuploid
lesions was higher than that for lesions with a diploid pattern. The determination of growth fractions with a
monoclonal antibody (DNA polymerase a) may be a biological marker of great prognostic significance.
The proliferative potential of tumours is a useful index of
their grade of malignancy. It is of paramount importance
therefore to know the proliferative potential of a tumour
both for choosing therapeutic methods and for predicting the
prognosis. The 3H-thymidine labelling index or the mitotic
index have so far been used for this purpose (Sasaki et al.,
1977). More recently, the proliferative index determined by
flow cytometry (Barlogie et al., 1983; Lovett et al., 1984) or
BrdU labelling index (BrdU is said to localise in cells in the
S-phase) have been used to examine the cell kinetics of
tumours (Gratzner, 1982).
DNA polymerase ox is an enzyme playing a central role in
DNA replication in mammalian cells (Weissbach, 1979; Sarn-
gadharan et al., 1978). The production of a monoclonal
antibody against DNA polymerase a provided a new method
for detecting proliferating cells (Bensch et al., 1982; Mat-
sukage et al., 1982; Masaki et al., 1982; Tanaka et al., 1982;
Yagura et al., 1987). Bensch et al. (1982) demonstrated intra-
nuclear distribution of the enzyme in human cells by
immunohistochemical techniques with monoclonal antibodies
against the human enzyme. In this study, the cell kinetics of
large bowel tumours were examined with a monoclonal
antibody against DNA polymerase a, to determine its
usefulness as an index of the grade of malignancy of these
tumours.
Materials and methods
A total of 54 lesions was studied: seven colorectal adenomas
removed by endoscopic polypectomy and 47 colorectal
cancers surgically resected in the authors' department. The 47
cancers comprised 28 lesions of colon cancers and 19 lesions
of rectal cancers. By histological grading, 26 lesions were
classified as well differentiated adenocarcinoma, 19 as
moderately differentiated adenocarcinoma and two as
mucinous carcinoma. Lymph node metastases were positive
in 22 of the 47 cancers (46.8%). Twenty-two patients had
Dukes' stage A cancers, four patients had Dukes' stage B
cancers, 13 patients had Dukes' stage C cancers, and eight
patients had Dukes' stage D tumours by Dukes classification.
Immunohistochemical method
Cancerous tissue obtained from the resected specimens was
snap-frozen and then frozen sections 6 ym in thickness were
cut. After air-drying, the sections were fixed with 3% PFA
(paraform aldehyde) for 30 min at 4°C. They were then
washed with phosphate buffered saline (PBS) for 10 min.
These sections were incubated with 1:50 diluted a mono-
clonal antibody against DNA polymerase a (CL22-2-42B,
MBL) (Masaki et al., 1982) overnight at room temperature.
After washing in PBS, they were allowed to react with a
25-fold dilution of rabbit to mouse IgG (DAKO), used as the
secondary antibody, for 60 min at room temperature. Finally
they were incubated with mouse PAP for 60 min and the
sections were then rinsed with PBS. The peroxidase activity
was developed using 3-3'-diaminobenzene tetrahydrochloride
until nuclear staining was easily detectable. The sections were
counterstained with methyl green for 20 min. DNA poly-
merase a positive cells exhibited deposits of brown DAB
precipitates. Immunoactive tumour cells could be easily dis-
tinguished from unreactive tumour cells. This monoclonal
antibody against DNA polymerase a was produced by
Masaki et al. (1982). Non-immune mouse serum was sub-
stituted for primary antibody on each section to serve as a
negative control. The number of stained cells per 1,000
tumour cells was counted using a standard light microscope
equipped with an ocular reticle. Areas of the section with the
highest labelling rate were used for counting.
Sample preparation andflow cytometric study
Flow cytometric analysis of cellular DNA content were per-
formed on 37 colorectal cancer. Three sections 30 gim in
thickness were obtained from the paraffin blocks of the
tumours. The tissue was deparaffinised with xylene, and then
progressively rehydrated in decreasing concentrations of
alcohol. After the specimen was washed with distilled water,
it was incubated in a 0.5% pepsin solution (Sigma Chemical
Co.). The specimens were then filtered through a 40 ym filter
and centrifugated. The remaining pellet was washed with
saline solution and incubated in Hanks' solution containing
0.2% EDTA and 0.01% RNase for 30 min at 37°C. Pro-
pidium iodide solution (Sigma) in RPMI, at a final concen-
tration of 100 mg l' was added to the single-cell preparation
as a DNA stain. The DNA content of the cells was measured
by a flow cytometer (EPICS). A minimum of 10,000 cells was
analysed by FCM for each specimen. A tumour with a single
Go/, was considered diploid, and diploid samples were
assigned a DNA index of 1.00. The finding of an additional
GI peak indicated the presence of aneuploidy.
Statisticalprocessing
Data are presented as the mean ± standard deviation. Statis-
tical analysis was performed using Student's t test.
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Differences were assumed significant when P was less then
0.05.
Results
In normal rectal mucosa DNA polymerase a positive cells
were scattered in the nuclei of gland cells. In the tissue of
colorectal cancers, immunohistochemical staining with
monoclonal antibody against DNA polymerase a were
diffusively distributed (Figure 1). The rate of DNA poly-
merase a positive cells in the 47 cancers ranged from 24.0 to
62.7% (mean 44.2 ± 9.2%), a figure that was significantly
higher than the 12.4-39.7% (mean 24.5 ± 8.9%) seen in
adenomas (Figure 2). There was no difference in the rate of
DNA polymerase a positive cells between rectal and colonic
cancers. The DNA polymerase a cell rate was 44.7% for
colonic cancer and 43.6% for rectal cancer.
The 47 lesions of large bowel cancers were examined to
determine the relationship between the histopathological
findings and the rate of DNA polymerase a positive cells.
The DNA polymerase a positive rate tended to rise as the
degree of histological differentiation decreased, being 40.1%
for well differentiated adenocarcinoma, 49.7% for moderately
differentiated adenocarcinoma and 46.4% for the mucinous
tumours (Table I).
In relation to the depth of penetration into the bowel wall,
the positive rate was 42.6% for the lesions without serosal
invasion, and 48.4% for those invading the serosal mem-
brane. Large numbers of DNA polymerase a positive cells
were found in cancers with venous invasion (Table I), but
there was no relationship between the rate of DNA
polymerase a positive cells and lymphatic invasion or the
presence of lymph node metastasis (Table II).
Figure I Immunostaining of colon cancer. a, negative control; b,
DNA polymerase a positive cells were found throughout the
cancer nest (x 400).
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Figure 2 Growth fraction of seven colorectal adenoma lesions
and 47 large bowel cancers determined by immunostaining with
the monoclonal antibody against DNA polymerase a.
Table I Correlation ofthe DNA polymerase a positive cells rate and
clinicopathological findings
No. of DNA polymerase a
cases positive cells rate (%)
Histological grading
Well differentiated 26 40.1 + 6.6
Moderately differentiated 19 49.7± 9.1]
Mucinous 2 46.4 ± 17.0
Invasion of bowel wall
Partiala 34 42.6 ± 8.8
Totalb 13 48.4 ± 9.6
Lymphatic invasion
Negative 20 42.8 ± 9.2
Positive 27 45.3 9.2
Venous invasion
Negative 15 41.9 8.5
Positive 32 49.3 8.8
a Tumours without serosal invasion. b Tumours with serosal invasion.
*P< 0.01.
In relation to Dukes' staging, the percentage of DNA
polymerase ac positive cells was 41.4% in Dukes' A tumours,
46.8% in Dukes' B tumours, 42% in Dukes' C tumours and
55.1% in Dukes' D lesions (Table III). In addition, the rate
of DNA polymerase a positive cells was 55.1% in patients
with liver metastasis, which was significantly higher than in
cases without liver metasatasis (P< 0.01) (Table II).
In the 14 patients who had tumours with over 50%
polymerase a positive cells, eight (57%) have proved to be
inoperable.
Finally, 13 tumours (35.1%) were diploid and 24 (64.9%)
were aneuploid. Table IV shows the relationship between the
rate of DNA polymerase a positive cells and the DNA ploidy
patterns. The rate was higher for lesions with the aneuploid
pattern than for diploid lesions (P <0.05). Specifically, the
percentage of DNA polymerase a positive cells was 39.8%
for the diploid lesions and 46.6% for the aneuploid lesions.
Table II Comparison ofthe rate ofDNA polymerase ot positive cells
with lymph node and liver metastases
No. of DNA polymerase a
cases positive cells rate (%)
Lymph node metastasis
Negative 25 42.7 ± 8.8
Positive 22 46.0 ± 9.5
Liver metastasis
Positive 8 55.1 + 6.0
Negative 39 41.7 ± 8.0
* P< 0.01.392 A. YAMAGUCHI et al.
Table HI Correlation ofthe rate ofDNA polymerase a positive cells
with the Dukes' stage
No. of DNA polymerase a
Dukes' stage cases positive cells rate (%)
A 22 41.4 8.3
B 4 46.8 10.6
C 13 42.0 7.61 *
D 8 55.1 6.0J
*P< 0.01
Table IV Relationship between the DNA polymerase a positive cells
rate and the DNA ploidy patterns
DNA No. of DNA polymerase a
ploidy pattern cases positive cells rate (%)
Diploid 13 39.8+8.9
Aneuploid 24 46.6 + 9.1 1 *
*P< 0.05.
Discussion
Recent reports have argued that the grade of malignancy of
tumours varies with their biological characteristics. In other
words, the grade of malignancy depends on the proliferative
rate and the metastatic potential of a tumour. It is thus
important to know the malignant grade of a tumour in
choosing the therapeutic method and in predicting the prog-
nosis. The 3H-thymidine labelling index has been used to
learn the problems to be solved in determining the grade of
malignancy before putting it into clinical application. In
recent years, flow cytometry (Barlogie et al., 1983; Lovett et
al., 1984) and a monoclonal antibody to BrdU (an analogue
of thymidine) produced by Gatzner (1982) have been used in
examining cell cycle kinetics. However, these methods involve
a few problems in their clinical use. Ki-67, presumably a
protein present in the nucleus of proliferating cells in the late
G1, S, G2 and M phase (Gerdes et al., 1984), may be an
index of the malignancy grade of tumours because the rate of
Ki-67 positive cells correlates with the histological grading
when Ki-67 labelling is carried out in breast cancer, colorec-
tal cancer and brain tumour (Gerdes et al., 1986; McGunin
et al., 1987; Lelle et al., 1987; Burger et al., 1986; Yamaguchi
et al., 1988). However, recently Van Dierendonck et al.
(1989) reported that Ki-67 fractions may not always be a
reliable indicator of growth fraction. So in this study the cell
kinetics of large bowel tumours were examined by the use of
a monoclonal antibody against DNA polymerase a.
Some literature has shown a marked rise in the level of
DNA polymerase a when cells were stimulated to divide
(Chang & Bollum, 1973; Baril et al., 1973). DNA polymerase
a, the major DNA polymerase in growing mammalian cells,
is the most important enzyme in DNA replication (Weiss-
bach, 1979; Sarngadharan et al., 1978). It is believe that
DNA polymerase a localises in the nucleus of proliferative
cells in the G1, S and G2 phases of transformed human cells,
and shows a scattered cytoplasmic distribution in M phase of
the cell cycle, but that it is not found in resting cells (Bensch
et al., 1982; Matsukage et al., 1983; Nakamura et al., 1984).
The monoclonal antibody against DNA polymerase a which
we have used was reported by Masaki et al. in 1982. This
antibody recognises a nuclear antigen which is expressed in
cycling cells. So the detection of DNA polymerase a seems to
be effective for estimating the proliferative activity of cells. It
has been reported that DNA polymerase a was detected
using the monoclonal antibody in normal and neoplastic
tissue of the uterine cervix (Mushika et al., 1988). No report
has been available to date on the cell kinetics of gastrointes-
tinal tumours using this method of investigation. In this
study, we found that some normal cell nuclei showed a DNA
polymerase a positive pattern in the zone adjacent to the
tumours. The rate of DNA polymerase a positive cells in
adenoma was 24.5% on average, but the rate for colorectal
cancer was a much higher (44.8% on average). In relation to
the DNA ploidy pattern, the rate of DNA polymerase a
positive cells for aneuploid lesions was higher than for those
with a diploid pattern. It has been said that tumour DNA
content is an independent prognostic indicator in patients
with colorectal cancer (Wolley et al., 1982; Scott et al., 1987;
Kokal et al., 1986; Armitage et al., 1985). The correlation of
DNA polymerase a staining with the DNA ploidy pattern
suggests the usefulness of DNA polymerase a positive cells
rate in judging the malignancy grade of carcinoma.
The DNA polymerase a positive cells rate was histopatho-
logically examined in large bowel cancer lesions. The results
revealed that the ratio of positive cells was increased as the
degree of differentiation of cancer decreased. For patients
with total invasion of the large bowel wall, the rate of DNA
polymerase a positive cells was higher than for those with
partial invasion of large bowel wall, and the rate of DNA
polymerase a positive cells also correlated with the presence
of venous invasion or liver metastasis. In other words, the
rate of antibody positivity seemed to allow the rate of pro-
liferating cells to be estimated, thus helping to predict the
tendency for invasion and the proliferative potential of the
tumours. Although this study was retrospective in nature, the
rate of DNA polymerase a positive cells can also be analysed
with biopsy specimens. Thus, DNA polymerase a positive cell
rate may possibly be a useful prognostic marker for colo-
rectal cancers.
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